| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.3 |